Legal & General Group
APLT

Legal & General Group’s Applied Therapeutics APLT Stock Holding History

Legal & General Group’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-56,114
Closed -$27.4K – 3426
2025
Q1 		$27.4K Sell
56,114
-27,904
-33% -$16.4K ﹤0.01% 2835
2024
Q4 		$71.9K Buy
84,018
+62,686
+294% +$393K ﹤0.01% 2745
2024
Q3 		$181K Buy
21,332
+4,195
+24% +$24.7K ﹤0.01% 2689
2024
Q2 		$79.7K Buy
+17,137
New +$81.1K ﹤0.01% 2746
2022
Q2 		– Sell
-5,618
Closed -$12K – 3526
2022
Q1 		$12K Hold
5,618
– – ﹤0.01% 3355
2021
Q4 		$50K Hold
5,618
– – ﹤0.01% 3032
2021
Q3 		$93K Buy
5,618
+3,255
+138% +$56.2K ﹤0.01% 2867
2021
Q2 		$49K Buy
2,363
+239
+11% +$4.52K ﹤0.01% 2953
2021
Q1 		$40K Sell
2,124
-72
-3% -$1.55K ﹤0.01% 2888
2020
Q4 		$48K Hold
2,196
– – ﹤0.01% 2811
2020
Q3 		$46K Sell
2,196
-570
-21% -$14.8K ﹤0.01% 2716
2020
Q2 		$100K Buy
2,766
+1,526
+123% +$63.9K ﹤0.01% 2531
2020
Q1 		$41K Sell
1,240
-56
-4% -$2.26K ﹤0.01% 2663
2019
Q4 		$35K Buy
+1,296
New +$22.2K ﹤0.01% 2972

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Legal & General Group's APLT Position: Q2 2025 in Review

Legal & General Group sold out of Applied Therapeutics (APLT) in Q2 2025, closing a stake of 56,114 shares — an estimated $27.4K sold.

Legal & General Group first reported a position in APLT in Q4 2019 and held it in 14 quarters. The position peaked at $181K in Q3 2024. 75 funds tracked by Wall St. Rank hold APLT as of Q2 2025.

  • Legal & General Group reported no remaining Applied Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 56,114 Applied Therapeutics shares in Q2 2025, an estimated $27.4K.
  • Legal & General Group first reported a position in Applied Therapeutics in Q4 2019 and held it in 14 quarters.
  • Legal & General Group's Applied Therapeutics position peaked at $181K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.